Glenmark Pharma gets USFDA nod for generic drug

Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator to market Sirolimus tablets, an immunosuppressant, in the American market. The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV's Rapamune tablets, Glenmark Pharmaceuticals said in a statement.

from IndiaTV India: Google News Feed https://ift.tt/35ccTOZ
via